Fused pyrrolidino-cyclopropane derivatives as selective...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/407 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2735286

The present invention relates to fused pyrrolidino-cyclopropane derivatives according to Formulae (I) to (II), as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1(11-.beta.- HSD-1 ) and the use of such compounds for the treatment and/or prevention of metabolic syndrome, diabetes, insulin resistance, obesity, lipid disorders, glaucoma, osteoporosis/ cognitive disorders, anxiety, depression, immune disorders, hypertension and other diseases and conditions.

Cette invention concerne des dérivés de la fusion pyrrolidino-cyclopropane selon les formules (I) à (ll), utilisés en tant quinhibiteurs sélectifs de lenzyme 11-bêta-hydroxystéroïde déshydrogénase de type 1 (11-ß-HSD-1 ) et lutilisation de ces composés dans le traitement et/ou la prévention du syndrome métabolique, du diabète, de linsulinorésistance, de lobésité, des troubles lipidiques, du glaucome, de lostéoporose, des troubles cognitifs, de lanxiété, de la dépression, des affections immunitaires, de lhypertension et dautres maladies et pathologies.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fused pyrrolidino-cyclopropane derivatives as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused pyrrolidino-cyclopropane derivatives as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pyrrolidino-cyclopropane derivatives as selective... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1889572

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.